HIGHLIGHTS
- who: Lingling Wang et al. from the Department of Laboratory Diagnosis, The Second Affiliated Hospital of Harbin Medical University, Harbin, University, China have published the paper: AIF-1, a potential biomarker of aggressive tumor behavior in patients with non-small cell lung cancer, in the Journal: PLOS ONE of December/15,/2022
- what: The aim of this study was to explore whether AIF-1 may play a role in the development of NSCLC. In view of the above results, experiments were carried out to determine whether the effects of rAIF-1 on the expressions of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.